BCM
ALXA

BBT Capital Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

BBT Capital Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-118,033
Closed -$539K – 293
2014
Q2 		$539K Hold
118,033
– – 0.03% 204
2014
Q1 		$523K Hold
118,033
– – 0.02% 255
2013
Q4 		$558K Hold
118,033
– – 0.03% 269
2013
Q3 		$604K Sell
118,033
-14,500
-11% -$68.2K 0.03% 261
2013
Q2 		$575K Buy
+132,533
New +$601K 0.03% 254

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return

BBT Capital Management's ALXA Position: Q3 2014 in Review

BBT Capital Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q3 2014, closing a stake of 118,033 shares — an estimated $539K sold.

BBT Capital Management first reported a position in ALXA in Q2 2013 and held it in 5 quarters. The position peaked at $604K in Q3 2013. 38 funds tracked by Wall St. Rank hold ALXA as of Q3 2014.

  • BBT Capital Management reported no remaining Alexza Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • BBT Capital Management sold 118,033 Alexza Pharmaceuticals Inc shares in Q3 2014, an estimated $539K.
  • BBT Capital Management first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • BBT Capital Management's Alexza Pharmaceuticals Inc position peaked at $604K in Q3 2013.
  • 38 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q3 2014.

Based on BBT Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.